Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma.

Oncoimmunology · 2016 · PMC4938306 · PMID 27471639

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Vorinostat treatment also seemed to upregulate the expression of MHCI on the tumor cells in vivo , but this did not reach statistical significance ( Fig. 4A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.